Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
178,568,993
-
Shares change
-
+1,073,442
-
Total reported value, excl. options
-
$1,801,785,844
-
Value change
-
+$4,161,742
-
Put/Call ratio
-
9.8%
-
Number of buys
-
88
-
Number of sells
-
-97
-
Price
-
$10.09
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q1 2020
227 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q1 2020.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 178,568,993 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (22,064,270 shares), BROWN CAPITAL MANAGEMENT LLC (17,960,849 shares), VANGUARD GROUP INC (16,341,190 shares), Sarissa Capital Management LP (13,525,000 shares), BlackRock Inc. (13,340,266 shares), FMR LLC (11,056,713 shares), UBS ASSET MANAGEMENT AMERICAS INC (7,855,891 shares), JANUS HENDERSON GROUP PLC (7,216,224 shares), STATE STREET CORP (5,852,637 shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (4,785,126 shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.